Orkambi Drug Interactions
Currently displaying 238 drugs known to have a major interaction with Orkambi (ivacaftor / lumacaftor).
- 238 major drug interactions
- 288 moderate drug interactions
- 8 minor drug interactions
Major interactions with Orkambi (ivacaftor / lumacaftor)
Note: Showing generic names only.
A
- abemaciclib
- abiraterone
- acalabrutinib
- adagrasib
- alpelisib
- amlodipine
- amprenavir
- apalutamide
- apixaban
- apremilast
- aprepitant
- aripiprazole
- atazanavir
- atogepant
- avacopan
- avapritinib
- axitinib
B
- bedaquiline
- belumosudil
- berotralstat
- boceprevir
- bortezomib
- bosutinib
- brexpiprazole
- brigatinib
- buspirone
- butorphanol
C
- cabozantinib
- capivasertib
- capmatinib
- carbamazepine
- cariprazine
- ceritinib
- chloramphenicol
- clarithromycin
- cobicistat
- cobimetinib
- colchicine
- conivaptan
- copanlisib
- crizotinib
- cyclosporine
D
- daclatasvir
- darolutamide
- darunavir
- dasatinib
- deflazacort
- delavirdine
- diltiazem
- doravirine
- dronedarone
- drospirenone
- duvelisib
E
- edoxaban
- elacestrant
- eliglustat
- elvitegravir
- encorafenib
- entrectinib
- enzalutamide
- eravacycline
- erdafitinib
- erlotinib
- erythromycin
- ethinyl estradiol
- etonogestrel
- etravirine
- everolimus
F
- fedratinib
- felodipine
- fentanyl
- fexinidazole
- finerenone
- flibanserin
- fluconazole
- fosamprenavir
- fosaprepitant
- fosphenytoin
- fostamatinib
- fostemsavir
- fruquintinib
G
H
I
- ibrexafungerp
- ibrutinib
- idelalisib
- imatinib
- indinavir
- infigratinib
- irinotecan
- irinotecan liposomal
- isavuconazonium
- isradipine
- istradefylline
- itraconazole
- ivabradine
- ivosidenib
- ixabepilone
- ixazomib
K
L
- lapatinib
- larotrectinib
- lefamulin
- leflunomide
- lemborexant
- lenacapavir
- leniolisib
- letermovir
- levamlodipine
- levoketoconazole
- levomethadyl acetate
- levonorgestrel
- lomitapide
- lonafarnib
- lorlatinib
- lovastatin
- lumateperone
- lurasidone
- lurbinectedin
M
- macitentan
- maraviroc
- maribavir
- mavacamten
- medroxyprogesterone
- mefloquine
- methadone
- mibefradil
- midazolam
- midostaurin
- mipomersen
- mitapivat
- mitotane
- mobocertinib
- morphine
N
- naldemedine
- naloxegol
- nefazodone
- nelfinavir
- neratinib
- nicardipine
- nifedipine
- nilotinib
- nimodipine
- nintedanib
- nirogacestat
- norethindrone
- norgestrel
O
P
- pacritinib
- palbociclib
- palovarotene
- panobinostat
- pemigatinib
- pexidartinib
- phenobarbital
- phenytoin
- pimozide
- pirtobrutinib
- pitolisant
- posaconazole
- pralsetinib
- praziquantel
- pretomanid
- primidone
Q
R
- ranolazine
- relugolix
- repotrectinib
- ribociclib
- rifabutin
- rifampin
- rifapentine
- rilpivirine
- rimegepant
- ripretinib
- risperidone
- ritonavir
- rivaroxaban
- rolapitant
S
- saquinavir
- selpercatinib
- selumetinib
- simeprevir
- simvastatin
- siponimod
- sirolimus
- sirolimus protein-bound
- sonidegib
- sotorasib
- sparsentan
- st. john's wort
- stiripentol
- sunitinib
- suvorexant
T
- tacrolimus
- tasimelteon
- tazemetostat
- telaprevir
- telithromycin
- temsirolimus
- tepotinib
- teriflunomide
- ticagrelor
- tivozanib
- tofacitinib
- tolvaptan
- toremifene
- trabectedin
- triazolam
- troleandomycin
- tucatinib
U
V
- valbenazine
- vemurafenib
- venetoclax
- verapamil
- voclosporin
- vonoprazan
- vorapaxar
- voriconazole
- voxelotor
Z
Orkambi alcohol/food interactions
There are 2 alcohol/food interactions with Orkambi (ivacaftor / lumacaftor).
Orkambi disease interactions
There are 6 disease interactions with Orkambi (ivacaftor / lumacaftor) which include:
More about Orkambi (ivacaftor / lumacaftor)
- Orkambi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CFTR combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.